Publication | Open Access

Clinical outcome of patients with various advanced cancer types vaccinated with an optimized cryptic human telomerase reverse transcriptase (TERT) peptide: results of an expanded phase II study

Clinical OutcomeOncologyReverse VaccinologyMedicineImmunologyTherapeutic VaccineImmune Checkpoint InhibitorImmunotherapyMolecular DiagnosticsRadiation OncologyTumor MicroenvironmentCancer Research